AI Finds Hidden Osteoporosis in Everyday CT Scans, Study Shows

Millions of computed tomography scans are performed every day for reasons that have nothing to do with bone health—chest pain, abdominal complaints, trauma workups, cancer staging. Yet hidden inside those routine images lies a treasure trove of information about the skeleton that radiologists rarely exploit. A new study published in BMC Medical Imaging suggests that commercially available artificial intelligence software can mine these ordinary non-contrast CT scans for signs of osteoporosis, potentially turning every abdominal or spinal scan into an unsolicited bone-density test. The research, led by a team at Changzheng Hospital of Naval Medical University in Shanghai, offers a quantitative assessment of just how well such opportunistic screening performs against the clinical gold standard.

Osteoporosis is a silent disease by design. Bone mineral drains away for decades without pain or symptoms until a fragility fracture—often of the hip, spine, or wrist—suddenly changes a person’s life. The diagnosis matters enormously for prevention, because effective medications can slow or reverse bone loss and dramatically reduce fracture risk once the condition is identified. The problem is identification. The standard diagnostic tool, dual-energy X-ray absorptiometry, or DXA, is safe, inexpensive, and fast, but it is underused: many people who would qualify for testing never receive it, particularly older adults in primary care settings who fall through the cracks of screening guidelines.

The Shanghai team set out to answer a deceptively simple question: if an AI algorithm reads the lumbar spine on a routine non-contrast CT scan—something already acquired for countless other reasons—how closely does its verdict match what DXA would say? Their retrospective study enrolled 518 patients who had undergone both DXA and lumbar non-contrast CT, allowing direct comparison of the two modalities in the same individuals. Based on the DXA results, each patient’s bone quality was classified into one of three standard categories: normal, osteopenia (reduced bone mass not yet severe enough for an osteoporosis diagnosis), or osteoporosis.

The technology at the heart of the study is built on convolutional neural networks, the deep learning architecture that has transformed medical image analysis. The commercial AI software automatically segmented the vertebral bodies on the CT scans—drawing precise boundaries around each vertebra without human input—and then extracted volumetric bone mineral density, or vBMD, values from the thoracic vertebra T12 down through the lumbar vertebra L2. This is a key technical distinction from DXA. DXA measures area bone mineral density, a two-dimensional projection expressed in grams per square centimeter, whereas CT provides true three-dimensional volumetric density in milligrams per cubic centimeter, separating dense cortical shell from the trabecular interior where bone loss typically begins.

Because there is no single obvious way to summarize density across three vertebrae, the researchers devised four different classification strategies. Method 1 averaged the vBMD across all three vertebrae, T12 plus L1 plus L2. Method 2 averaged only T12 and L1. Method 3 averaged T12 and L2, and method 4 averaged L1 and L2. Each strategy produced its own bone-quality classification, allowing the team to determine which vertebral combination best captured the true skeletal status as defined by DXA. This kind of head-to-head comparison of measurement windows is practically important, because in real-world CT scans the field of view does not always include the same vertebrae from patient to patient.

To evaluate agreement, the researchers deployed a battery of statistical instruments. Intraclass correlation coefficients measured how consistently the AI-derived density values tracked with DXA across the cohort. Bland-Altman analysis examined whether the differences between the two methods were systematically biased or randomly scattered across the range of bone densities. Linear Cohen’s weighted kappa statistics quantified how often the categorical verdicts—normal, osteopenia, or osteoporosis—matched between modalities, with weighting that accounts for how far apart disagreements fall on the ordered scale. Multi-categorical logistic regression and receiver operating characteristic curves then estimated the diagnostic performance of each of the four AI-based classification methods, with a p-value below 0.05 serving as the threshold for statistical significance.

The results paint a picture of a technology that works well, though not perfectly. The four AI-based methods agreed remarkably with one another, posting an intraclass correlation coefficient of 0.909 with a 95 percent confidence interval of 0.893 to 0.923—meaning the choice of vertebral window matters far less than one might fear. Agreement between the AI methods and DXA was good but more modest: the ICCs ranged from 0.649 for method 2 (T12 plus L1) to 0.689 for method 1 (T12 plus L1 plus L2), with methods 3 and 4 falling in between at 0.666 and 0.680 respectively. These coefficients indicate substantial, clinically useful concordance, while also reflecting the inherent differences between two-dimensional areal and three-dimensional volumetric density measurements.

The most striking numbers came from the decision function that separates osteoporosis from the combined pool of normal and osteopenic patients. Here the AI achieved a precision of 0.834—meaning that when it flags a patient as osteoporotic, it is right about 83 percent of the time—and a recall of 0.735, meaning it catches roughly three-quarters of true osteoporosis cases. In screening terms, that combination is compelling. A missed case can still be caught at a later scan, while a false alarm simply triggers a confirmatory DXA, a cheap and harmless test. Among the four approaches, the three-vertebra average of T12, L1, and L2—the method that draws on the most bone data—showed the best diagnostic performance overall.

The implications reach well beyond a single hospital in Shanghai. Opportunistic screening of this kind requires no additional radiation, no additional scanner time, and no additional patient visit; the AI simply runs in the background on images that already exist. If validated across diverse populations and scanner types, such software could quietly build a bridge between the enormous volume of routine CT imaging and the stubbornly underdiagnosed population of people with brittle bones. Every abdominal scan performed for kidney stones or appendicitis could double as a skeletal health check, flagging patients who should be referred for confirmatory testing and treatment before their first fracture.

Cautions remain, as they must with any retrospective, single-center study. The cohort of 518 patients underwent both DXA and lumbar CT, a population that may not represent the general screening-age public, and the software was a specific commercial product whose performance could vary with different CT acquisition parameters or patient demographics. The study was also approved by the Medical Ethical Review Committee of Shanghai Changzheng Hospital with informed consent waived due to its retrospective design, and it was supported by the National Natural Science Foundation of China and other Chinese funding bodies, which had no role in the study design or analysis. Still, the core finding stands on its own: AI-driven vBMD extraction from routine non-contrast CT agrees well with DXA, and the simplest strategy—averaging density across T12 through L2—performs best. The era in which every CT scan quietly doubles as a bone-density test may be closer than anyone expected.

Subject of Research: AI-driven opportunistic osteoporosis screening using volumetric bone mineral density from routine non-contrast CT compared with DXA

Article Title: The diagnostic accuracy of AI-driven opportunistic osteoporosis screening based on routine non-contrast CT

Article References: Zhao, B., Sun, K., Shen, Q., Zhang, T., Xu, S., Qian, B., Ni, J., Duan, G., Wang, X., & Xiao, Y. (2026). The diagnostic accuracy of AI-driven opportunistic osteoporosis screening based on routine non-contrast CT. BMC Medical Imaging. https://doi.org/10.1186/s12880-026-02812-3

Image Credits: AI Generated

DOI: 10.1186/s12880-026-02812-3

Keywords: osteoporosis, artificial intelligence, computed tomography, DXA, bone mineral density, opportunistic screening, radiology, machine learning, convolutional neural networks, volumetric BMD, osteopenia, medical imaging